HomeSBS • ETR
add
Stratec SE
Previous close
€45.05
Day range
€44.50 - €45.65
Year range
€36.00 - €61.30
Market cap
555.81M EUR
Avg Volume
6.58K
P/E ratio
45.24
Dividend yield
1.22%
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 50.87M | -15.89% |
Operating expense | 10.91M | 5.09% |
Net income | 447.00K | -67.35% |
Net profit margin | 0.88 | -61.06% |
Earnings per share | — | — |
EBITDA | 6.80M | -5.43% |
Effective tax rate | 25.62% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.13M | -28.01% |
Total assets | 448.08M | 10.27% |
Total liabilities | 218.86M | 24.18% |
Total equity | 229.22M | — |
Shares outstanding | 12.16M | — |
Price to book | 2.39 | — |
Return on assets | 1.18% | — |
Return on capital | 1.44% | — |
Cash Flow
Net change in cash
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 447.00K | -67.35% |
Cash from operations | 2.44M | -59.12% |
Cash from investing | -4.32M | 15.80% |
Cash from financing | -12.52M | -775.19% |
Net change in cash | -14.40M | -636.75% |
Free cash flow | 3.17M | -74.60% |
About
STRATEC SE is a company with worldwide operations that develops and produces analyzer systems and automation systems in the field of in-vitro-diagnostics. As a classic OEM supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also develops system software and software to connect the systems to laboratory software. STRATEC is also responsible for development documentation, testing and delivering the systems, and supplying spare parts and consumables. STRATEC's customers are well known diagnostic companies like SIEMENS, Bio-Rad or Hologic. Wikipedia
Founded
1979
Website
Employees
1,473